Inventor
SHANNON JONATHAN
GB20 patents
⚠️ This page may combine multiple inventors who share the name “SHANNON JONATHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFLAZOME LTD
15 patentsUS11370776B2Jun 28, 2022
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD6 citations73
US11542255B2Jan 3, 2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD2 citations70
US11613542B2Mar 28, 2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD2 citations69
US11926600B2Mar 12, 2024
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD1 citations62
US11981667B2May 14, 2024
Sulfonamide carboxamide compounds
INFLAZOME LTD1 citations61
US11623922B2Apr 11, 2023
Compounds
INFLAZOME LTD1 citations61
US11518739B2Dec 6, 2022
Sulfonamide carboxamide compounds
INFLAZOME LTD2 citations61
US11465992B2Oct 11, 2022
Sulfonamide carboxamide compounds
INFLAZOME LTD1 citations61
US12221434B2Feb 11, 2025
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations59
US11905252B2Feb 20, 2024
Compounds
INFLAZOME LTD0 citations51
US12168653B2Dec 17, 2024
Sulfonamide derivates as NLRP3 inhibitors
INFLAZOME LTD0 citations50
US12012392B2Jun 18, 2024
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations50
US11773058B2Oct 3, 2023
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations50
US12187702B2Jan 7, 2025
Sulfonamideurea compounds
INFLAZOME LTD0 citations47
US12030879B2Jul 9, 2024
Sulfonyl acetamides as NLRP3 inhibitors
INFLAZOME LTD0 citations44